These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8865524

  • 1. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
    de Maat MP, Arnold AE, van Buuren S, Wilson JH, Kluft C.
    Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
    [Abstract] [Full Text] [Related]

  • 2. [Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study].
    Tullio D, Valerio A, Ottaviano MA, Di Guglielmo L, Accettura P, Caraceni CE, Sclocco T.
    Minerva Med; 1990 Aug; 81(1-2):87-92. PubMed ID: 2179769
    [Abstract] [Full Text] [Related]

  • 3. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U, von Schenck H, Wallentin L.
    Thromb Haemost; 1985 Dec 17; 54(4):808-12. PubMed ID: 3911481
    [Abstract] [Full Text] [Related]

  • 4. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP, Madsen JS, Langdahl B, Bladbjerg EM, Tofteng CL, Abrahamsen B, Rejnmark L, Brixen K, Christensen K, Jespersen J, Kristensen SR.
    Thromb Haemost; 2007 Feb 17; 97(2):234-9. PubMed ID: 17264952
    [Abstract] [Full Text] [Related]

  • 5. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    Saha S, Berglund M, Sylvén C, Gordon A, Agewall S.
    Int J Cardiol; 2008 Jan 11; 123(2):195-6. PubMed ID: 17320208
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y, Gorenek B, Alpsoy S, Unalir A, Ata N, Timuralp B.
    Isr Med Assoc J; 2001 Jan 11; 3(1):13-6. PubMed ID: 11344793
    [Abstract] [Full Text] [Related]

  • 7. Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia.
    de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C.
    Thromb Haemost; 1997 Jan 11; 77(1):75-9. PubMed ID: 9031453
    [Abstract] [Full Text] [Related]

  • 8. Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine.
    Randi ML, Mares M, Fabris F, Tison T, Barbone E, Girolami A.
    Arzneimittelforschung; 1991 Apr 11; 41(4):414-6. PubMed ID: 1859515
    [Abstract] [Full Text] [Related]

  • 9. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
    Katsaros KM, Kastl SP, Huber K, Zorn G, Maurer G, Glogar D, Wojta J, Christ G, Speidl WS.
    Thromb Res; 2008 Apr 11; 123(1):79-84. PubMed ID: 18558425
    [Abstract] [Full Text] [Related]

  • 10. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG, Xu F, Zhang Y, Ji QS, Sun Y, Lü RJ, Li RJ.
    Chin Med J (Engl); 2006 Jan 05; 119(1):32-6. PubMed ID: 16454979
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J.
    Clin Pharmacol Ther; 2005 Nov 05; 78(5):468-76. PubMed ID: 16321613
    [Abstract] [Full Text] [Related]

  • 12. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M, Keren A, Banai S.
    Am Heart J; 2003 Feb 05; 145(2):248-53. PubMed ID: 12595841
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M, Latsios G, Aggelis D, Bosinakou I, Karambelas I, Tousoulis D, Toutouzas K, Stefanadis C.
    Clin Ther; 2006 Jun 05; 28(6):860-71. PubMed ID: 16860169
    [Abstract] [Full Text] [Related]

  • 14. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.
    Azar RR, Kassab R, Zoghbi A, Aboujaoudé S, El-Osta H, Ghorra P, Germanos M, Salamé E.
    Am Heart J; 2006 Feb 05; 151(2):521.e1-521.e4. PubMed ID: 16442924
    [Abstract] [Full Text] [Related]

  • 15. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.
    Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioï M, Lozniewski A, Loubinoux J, Le Faou A, Guéant JL.
    Am Heart J; 1999 Feb 05; 137(2):346-51. PubMed ID: 9924170
    [Abstract] [Full Text] [Related]

  • 16. C-reactive protein levels are influenced by common IL-1 gene variations.
    Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, Duff GW.
    Cytokine; 2002 Feb 21; 17(4):171-4. PubMed ID: 11991668
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns.
    Inami N, Nomura S, Kimura Y, Yamada K, Nakamori H, Takahashi N, Fukuhara S, Iwasaka T.
    Clin Appl Thromb Hemost; 2007 Oct 21; 13(4):428-31. PubMed ID: 17911196
    [Abstract] [Full Text] [Related]

  • 18. [The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test].
    Türkoğlu EI, Gürgün C, Zoghi M, Türkoğlu C.
    Anadolu Kardiyol Derg; 2004 Sep 21; 4(3):199-202. PubMed ID: 15355818
    [Abstract] [Full Text] [Related]

  • 19. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Lackner KJ, Tiret L, Münzel T, Blankenberg S, AtheroGene Investigators.
    Eur Heart J; 2006 Dec 21; 27(24):2962-8. PubMed ID: 17132649
    [Abstract] [Full Text] [Related]

  • 20. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct 21; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.